Healthcare - Biotechnology - NASDAQ - US
$ 36.85
-7.34 %
$ 14.2 B
Market Cap
-6.34
P/E
Price Target
Average
247.18%
Revenue Forecast
Estimate
--2.95%
EBIT
Estimate
21.40%
Net Income
Estimate
37.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Moderna, Inc.
Wall Street analysts predict an average 1-year price target for MRNA of $128 , with forecasts ranging from a low of $55 to a high of $310 .
MRNA Lowest Price Target
Wall Street Target
55 USD
49.25%
MRNA Average Price Target
Wall Street Target
128 USD
247.18%
MRNA Highest Price Target
Wall Street Target
310 USD
741.25%
REVENUE FORECAST
Revenue Forecast Chart MRNA
EBIT FORECAST
EBIT Forecast Chart MRNA
NET INCOME FORECAST
Net Income Chart MRNA